论文部分内容阅读
种接BCG后引起致死性的全身的感染曾有几例记载。有联合性的免疫缺陷或是选择性的细胞介导免疫缺陷的患者能导致此病。该病最突出的特征是:结核菌素试验无反应性,无结节形成,以及致死性结局。在治疗上曾用杭结核药,λ—球蛋旦白,和输血来阻止感染的致死性结局,均未成功。近年来,使用可透析的转移因子(TFd)治疗几例临胞内感染伴有细胞介导免疫缺陷的我者,其临床症状暂时好转,且细胞介导免疫恢复到了正常。本文报告一例10岁有细胞介导免疫缺陷的
There are several documented cases of systemic infections that cause fatalities after BCG. Patients with combined immunodeficiency or selective cell-mediated immune deficiency can cause the disease. The most prominent features of the disease are: tuberculin test non-responsive, non-nodular formation, and fatal outcome. In the treatment of tuberculosis drugs have been used, lambda-globulin, and blood transfusion to prevent the fatal outcome of infection, were unsuccessful. In recent years, the use of dialysis transfer factor (TFd) in the treatment of several cases of intracellular infection accompanied by cell-mediated immune deficiency, the clinical symptoms of the temporary improvement and cell-mediated immunity returned to normal. This article reports a 10-year-old cell-mediated immune deficiency